Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms

This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order to yield rabies-recombinant baculovirus, bearing genes of G (BVG) and M (BVM) proteins, and to obtain rabies virus-like particles (VLP) from t...

Full description

Saved in:
Bibliographic Details
Published inVaccines (Basel) Vol. 11; no. 1; p. 39
Main Authors Guardalini, Luis Giovani Oliveira, Cavalcante, Paulo Eduardo da Silva, Leme, Jaci, Mello, Renata Gois de, Bernardino, Thaissa Consoni, Jared, Simone Gonçalves Silva, Antoniazzi, Marta Maria, Astray, Renato Mancini, Tonso, Aldo, Fernández Núñez, Eutimio Gustavo, Jorge, Soraia Attie Calil
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 24.12.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order to yield rabies-recombinant baculovirus, bearing genes of G (BVG) and M (BVM) proteins, and to obtain rabies virus-like particles (VLP) from them, using Sf9 insect cells as a host. Equivalent assays in Schott flasks and a bioreactor were performed to compare both systems and a multivariate statistical approach was also carried out to maximize VLP production as a function of BVG and BVM's multiplicity of infection (MOI) and harvest time (HT). Viable cell density, cell viability, virus titer, BVG and BVM quantification by dot-blot, and BVG quantification by Enzyme-Linked Immunosorbent Assay (ELISA) were monitored throughout the assays. Furthermore, transmission electron microscopy was used to characterize rabies VLP. The optimal combination for maximum VLP expression was BVG and BVM MOI of 2.3 pfu/cell and 5.1 pfu/cell, respectively, and 108 h of harvest time. The current study confirmed that the utilization of Schott flasks and a benchtop bioreactor under the conditions applied herein are equivalent regarding the cell death kinetics corresponding to the recombinant baculovirus infection process in Sf9 cells. According to the results, the hydrodynamic and chemical differences in both systems seem to greatly affect the virus and VLP integrity after release.
AbstractList This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order to yield rabies-recombinant baculovirus, bearing genes of G (BVG) and M (BVM) proteins, and to obtain rabies virus-like particles (VLP) from them, using Sf9 insect cells as a host. Equivalent assays in Schott flasks and a bioreactor were performed to compare both systems and a multivariate statistical approach was also carried out to maximize VLP production as a function of BVG and BVM’s multiplicity of infection (MOI) and harvest time (HT). Viable cell density, cell viability, virus titer, BVG and BVM quantification by dot-blot, and BVG quantification by Enzyme-Linked Immunosorbent Assay (ELISA) were monitored throughout the assays. Furthermore, transmission electron microscopy was used to characterize rabies VLP. The optimal combination for maximum VLP expression was BVG and BVM MOI of 2.3 pfu/cell and 5.1 pfu/cell, respectively, and 108 h of harvest time. The current study confirmed that the utilization of Schott flasks and a benchtop bioreactor under the conditions applied herein are equivalent regarding the cell death kinetics corresponding to the recombinant baculovirus infection process in Sf9 cells. According to the results, the hydrodynamic and chemical differences in both systems seem to greatly affect the virus and VLP integrity after release.
Author Guardalini, Luis Giovani Oliveira
Jared, Simone Gonçalves Silva
Tonso, Aldo
Antoniazzi, Marta Maria
Astray, Renato Mancini
Fernández Núñez, Eutimio Gustavo
Cavalcante, Paulo Eduardo da Silva
Leme, Jaci
Bernardino, Thaissa Consoni
Mello, Renata Gois de
Jorge, Soraia Attie Calil
AuthorAffiliation 2 Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
5 Grupo de Engenharia de Bioprocessos, Escola de Artes, Ciências e Humanidades (EACH), Universidade de São Paulo, Rua Arlindo Béttio, 1000, São Paulo CEP 03828-000, SP, Brazil
4 Laboratório de Células Animais, Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo. Av. Prof. Luciano Gualberto, Trav. 3, 380, São Paulo CEP 05508-900, SP, Brazil
1 Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
3 Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
AuthorAffiliation_xml – name: 3 Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– name: 4 Laboratório de Células Animais, Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo. Av. Prof. Luciano Gualberto, Trav. 3, 380, São Paulo CEP 05508-900, SP, Brazil
– name: 5 Grupo de Engenharia de Bioprocessos, Escola de Artes, Ciências e Humanidades (EACH), Universidade de São Paulo, Rua Arlindo Béttio, 1000, São Paulo CEP 03828-000, SP, Brazil
– name: 1 Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– name: 2 Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
Author_xml – sequence: 1
  givenname: Luis Giovani Oliveira
  orcidid: 0000-0001-5143-7024
  surname: Guardalini
  fullname: Guardalini, Luis Giovani Oliveira
  organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 2
  givenname: Paulo Eduardo da Silva
  surname: Cavalcante
  fullname: Cavalcante, Paulo Eduardo da Silva
  organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 3
  givenname: Jaci
  surname: Leme
  fullname: Leme, Jaci
  organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 4
  givenname: Renata Gois de
  surname: Mello
  fullname: Mello, Renata Gois de
  organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 5
  givenname: Thaissa Consoni
  surname: Bernardino
  fullname: Bernardino, Thaissa Consoni
  organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 6
  givenname: Simone Gonçalves Silva
  surname: Jared
  fullname: Jared, Simone Gonçalves Silva
  organization: Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 7
  givenname: Marta Maria
  surname: Antoniazzi
  fullname: Antoniazzi, Marta Maria
  organization: Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 8
  givenname: Renato Mancini
  orcidid: 0000-0002-6983-5298
  surname: Astray
  fullname: Astray, Renato Mancini
  organization: Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
– sequence: 9
  givenname: Aldo
  orcidid: 0000-0001-8498-7348
  surname: Tonso
  fullname: Tonso, Aldo
  organization: Laboratório de Células Animais, Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo. Av. Prof. Luciano Gualberto, Trav. 3, 380, São Paulo CEP 05508-900, SP, Brazil
– sequence: 10
  givenname: Eutimio Gustavo
  orcidid: 0000-0002-2800-392X
  surname: Fernández Núñez
  fullname: Fernández Núñez, Eutimio Gustavo
  organization: Grupo de Engenharia de Bioprocessos, Escola de Artes, Ciências e Humanidades (EACH), Universidade de São Paulo, Rua Arlindo Béttio, 1000, São Paulo CEP 03828-000, SP, Brazil
– sequence: 11
  givenname: Soraia Attie Calil
  surname: Jorge
  fullname: Jorge, Soraia Attie Calil
  organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36679884$$D View this record in MEDLINE/PubMed
BookMark eNpdkttvFCEUxompsbXtu0-GxBdfxnIbLi8muvHSpIlN0za-EWCYlXUGVphZ9b-XdbdNW14gh-_8zuHwvQQHMUUPwCuM3lGq0NnGOBeiLxgjjBBVz8ARQYI3VNHvBw_Oh-C0lBWqS2EquXgBDinnQknJjsCfS5_7lEcTnYeLNK5NDiVFmHp45V0abYgmTvCjcfOQNiHPBZrYwStjgy_wdhtohvDTw0uTp-CGGlzn1M1uCpVyU0JcwuvfCS7mYZpzlQ1m2tYrJ-B5b4biT_f7Mbj5_Ol68bW5-PblfPHhonFMoanpWyl57VSqjihhvFWWCOcI8aIVrmdYso5Z6RlR1mOJsGXSWO6k7JGRztJjcL7jdsms9DqH0eS_Opmg_wdSXup955qyHilBOHXIMmKUbDm2qseipRixTlXW-x1rPdvRd87HKZvhEfTxTQw_9DJttKpjx7itgLd7QE6_Zl8mPYbi_DCY6NNcNBFcEkqY5FX65ol0leYc66i2KkGkrB9YVWincjmVkn1_3wxGeusS_dQlNeX1w0fcJ9x5gv4Db2m9ig
CitedBy_id crossref_primary_10_1002_jctb_7571
crossref_primary_10_1016_j_bej_2023_109013
crossref_primary_10_1016_j_saa_2024_124638
crossref_primary_10_1007_s12033_023_00759_2
Cites_doi 10.1080/14760584.2018.1516552
10.1038/s41598-020-57761-w
10.1007/s12033-021-00366-z
10.29245/2578-3009/2018/2.1118
10.1007/s00253-018-8962-0
10.2144/000113238
10.1016/j.jbiotec.2015.10.013
10.3390/pr8091179
10.1016/j.vaccine.2014.06.058
10.1007/BF00353943
10.1007/978-1-4939-3043-2_8
10.4149/av_2017_306
10.1007/978-1-4939-3387-7_7
10.1016/j.jbiotec.2012.05.016
10.1016/B978-0-12-801919-1.00005-1
10.1002/0471142735.ima03bs21
10.1002/bit.22192
10.1007/BF02521742
10.3390/v7031134
10.1007/s10616-008-9134-3
10.1099/jgv.0.001108
10.1080/00224065.1980.11980968
10.2807/1560-7917.ES.2020.25.38.2000158
10.1007/978-3-030-21084-7
10.1093/oxfordjournals.aje.a118408
10.1002/biot.200700179
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID NPM
AAYXX
CITATION
3V.
7T7
7XB
8FD
8FE
8FH
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
GNUQQ
GUQSH
HCIFZ
LK8
M2O
M7P
MBDVC
P64
PIMPY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.3390/vaccines11010039
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
ProQuest Central Student
Research Library Prep
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
Biological Sciences
ProQuest research library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef


Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2076-393X
ExternalDocumentID oai_doaj_org_article_34f097263c0b42a98561b9f1753104d9
10_3390_vaccines11010039
36679884
Genre Journal Article
GeographicLocations United States--US
New Jersey
GeographicLocations_xml – name: New Jersey
– name: United States--US
GrantInformation_xml – fundername: Universidade de São Paulo
  grantid: AUXPE PROAP CAPES
– fundername: National Council of Technological and Scientific Development (CNPq)
  grantid: 168539/2018-7
– fundername: University of São Paulo (USP)
– fundername: São Paulo Research Foundation (FAPESP)
  grantid: 2018/10538-1; 2016/22780-6
GroupedDBID 3V.
53G
5VS
8FE
8FH
8G5
AADQD
AAHBH
ABUWG
ADBBV
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
DIK
DWQXO
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
AAYXX
CITATION
7T7
7XB
8FD
8FK
C1K
FR3
MBDVC
P64
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c490t-f588688489d297aeb9b27cc22e757cf4184d4b8e429be1801b48ab6c88f0a8cb3
IEDL.DBID RPM
ISSN 2076-393X
IngestDate Tue Oct 22 15:04:34 EDT 2024
Tue Sep 17 21:30:31 EDT 2024
Fri Oct 25 05:04:30 EDT 2024
Sat Nov 09 13:25:47 EST 2024
Thu Sep 26 21:16:09 EDT 2024
Wed Oct 16 00:40:10 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords stirred-tank bioreactor
quality by design
viral infection
rabies virus-like particles
Sf9 cells
recombinant baculovirus
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c490t-f588688489d297aeb9b27cc22e757cf4184d4b8e429be1801b48ab6c88f0a8cb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8498-7348
0000-0002-6983-5298
0000-0002-2800-392X
0000-0001-5143-7024
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867115/
PMID 36679884
PQID 2767288988
PQPubID 2032320
ParticipantIDs doaj_primary_oai_doaj_org_article_34f097263c0b42a98561b9f1753104d9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9867115
proquest_miscellaneous_2768232486
proquest_journals_2767288988
crossref_primary_10_3390_vaccines11010039
pubmed_primary_36679884
PublicationCentury 2000
PublicationDate 20221224
PublicationDateYYYYMMDD 2022-12-24
PublicationDate_xml – month: 12
  year: 2022
  text: 20221224
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Vaccines (Basel)
PublicationTitleAlternate Vaccines (Basel)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Hopkins (ref_14) 2009; 47
Rao (ref_21) 2008; 102
Donaldson (ref_6) 2018; 17
Decarli (ref_9) 2018; 102
Saxena (ref_24) 2018; 99
Fontana (ref_5) 2016; 1403
Chan (ref_22) 2016; 1350
ref_13
Katz (ref_1) 2017; 61
Power (ref_25) 1992; 9
Swiech (ref_10) 2008; 57
Reed (ref_17) 1938; 27
ref_16
Changalucha (ref_2) 2021; 16
Dietzschold (ref_27) 2015; 2
Koraka (ref_28) 2014; 32
Kang (ref_26) 2015; 7
Rossi (ref_11) 2012; 161
ref_20
Palomares (ref_8) 1996; 22
Gossner (ref_3) 2020; 25
Bernardino (ref_15) 2021; 63
Astray (ref_18) 2008; 3
Derringer (ref_19) 1980; 12
Strobl (ref_12) 2020; 10
Dubois (ref_23) 2015; 216
ref_4
Dai (ref_7) 2018; 2
References_xml – volume: 17
  start-page: 833
  year: 2018
  ident: ref_6
  article-title: Virus-like particle vaccines: Immunology and formulation for clinical translation
  publication-title: Expert Rev. Vaccines
  doi: 10.1080/14760584.2018.1516552
  contributor:
    fullname: Donaldson
– volume: 10
  start-page: 1
  year: 2020
  ident: ref_12
  article-title: Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-57761-w
  contributor:
    fullname: Strobl
– volume: 63
  start-page: 1068
  year: 2021
  ident: ref_15
  article-title: Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach
  publication-title: Mol. Biotechnol.
  doi: 10.1007/s12033-021-00366-z
  contributor:
    fullname: Bernardino
– volume: 16
  start-page: 39
  year: 2021
  ident: ref_2
  article-title: Human rabies: Prospects for elimination
  publication-title: CAB Rev. Perspect. Agric. Veter- Sci. Nutr. Nat. Resour.
  contributor:
    fullname: Changalucha
– volume: 2
  start-page: 36
  year: 2018
  ident: ref_7
  article-title: Advances and challenges in enveloped virus-like particle (VLP)-based vaccines
  publication-title: J. Immunol. Sci.
  doi: 10.29245/2578-3009/2018/2.1118
  contributor:
    fullname: Dai
– volume: 102
  start-page: 4773
  year: 2018
  ident: ref_9
  article-title: DROSOPHILA S2 cell culture in a WAVE Bioreactor: Potential for scaling up the production of the recombinant rabies virus glycoprotein
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s00253-018-8962-0
  contributor:
    fullname: Decarli
– volume: 47
  start-page: 785
  year: 2009
  ident: ref_14
  article-title: A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line
  publication-title: Biotechniques
  doi: 10.2144/000113238
  contributor:
    fullname: Hopkins
– volume: 216
  start-page: 110
  year: 2015
  ident: ref_23
  article-title: Insect cell entrapment, growth and recovering using a single-use fixed-bed bioreactor. Scaling up and recombinant protein production
  publication-title: J. Biotechnol.
  doi: 10.1016/j.jbiotec.2015.10.013
  contributor:
    fullname: Dubois
– ident: ref_20
  doi: 10.3390/pr8091179
– volume: 32
  start-page: 4644
  year: 2014
  ident: ref_28
  article-title: A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.06.058
  contributor:
    fullname: Koraka
– volume: 22
  start-page: 225
  year: 1996
  ident: ref_8
  article-title: The effect of dissolved oxygen tension and the utility of oxygen uptake rate in insect cell culture
  publication-title: Cytotechnology
  doi: 10.1007/BF00353943
  contributor:
    fullname: Palomares
– volume: 1350
  start-page: 161
  year: 2016
  ident: ref_22
  article-title: Development of Serum-Free Media for Lepidopteran Insect Cell Lines
  publication-title: Baculovirus and Insect Cell Expression Protocols
  doi: 10.1007/978-1-4939-3043-2_8
  contributor:
    fullname: Chan
– volume: 61
  start-page: 280
  year: 2017
  ident: ref_1
  article-title: Large protein as a potential target for use in rabies diagnostics
  publication-title: Acta Virol.
  doi: 10.4149/av_2017_306
  contributor:
    fullname: Katz
– volume: 1403
  start-page: 155
  year: 2016
  ident: ref_5
  article-title: Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies
  publication-title: Vaccine Design
  doi: 10.1007/978-1-4939-3387-7_7
  contributor:
    fullname: Fontana
– volume: 161
  start-page: 328
  year: 2012
  ident: ref_11
  article-title: Effect of hypothermic temperatures on production of rabies virus glycoprotein by recombinant Drosophila melanogaster S2 cells cultured in suspension
  publication-title: J. Biotechnol.
  doi: 10.1016/j.jbiotec.2012.05.016
  contributor:
    fullname: Rossi
– volume: 2
  start-page: 47
  year: 2015
  ident: ref_27
  article-title: Purification of Rabies Virus and Its Subunits
  publication-title: Current Laboratory Techniques in Rabies Diagnosis, Research and Prevention
  doi: 10.1016/B978-0-12-801919-1.00005-1
  contributor:
    fullname: Dietzschold
– ident: ref_16
  doi: 10.1002/0471142735.ima03bs21
– volume: 102
  start-page: 348
  year: 2008
  ident: ref_21
  article-title: Disposable bioprocessing: The future has arrived
  publication-title: Biotechnol. Bioeng.
  doi: 10.1002/bit.22192
  contributor:
    fullname: Rao
– volume: 9
  start-page: 149
  year: 1992
  ident: ref_25
  article-title: Modelling the growth and protein production by insect cells following infection by a recombinant baculovirus in suspension culture
  publication-title: Cytotechnology
  doi: 10.1007/BF02521742
  contributor:
    fullname: Power
– volume: 7
  start-page: 1134
  year: 2015
  ident: ref_26
  article-title: Chimeric Rabies Virus-Like Particles Containing Membrane-Anchored GM-CSF Enhances the Immune Response against Rabies Virus
  publication-title: Viruses
  doi: 10.3390/v7031134
  contributor:
    fullname: Kang
– volume: 57
  start-page: 67
  year: 2008
  ident: ref_10
  article-title: Enhanced production of recombinant rabies virus glycoprotein (rRVGP) by Drosophila melanogaster S2 cells through control of culture conditions
  publication-title: Cytotechnology
  doi: 10.1007/s10616-008-9134-3
  contributor:
    fullname: Swiech
– volume: 99
  start-page: 1151
  year: 2018
  ident: ref_24
  article-title: A structured review of baculovirus infection process: Integration of mathematical models and biomolecular information on cell–virus interaction
  publication-title: J. Gen. Virol.
  doi: 10.1099/jgv.0.001108
  contributor:
    fullname: Saxena
– volume: 12
  start-page: 214
  year: 1980
  ident: ref_19
  article-title: Simultaneous Optimization of Several Response Variables
  publication-title: J. Qual. Technol.
  doi: 10.1080/00224065.1980.11980968
  contributor:
    fullname: Derringer
– ident: ref_13
– volume: 25
  start-page: 2000158
  year: 2020
  ident: ref_3
  article-title: Prevention of human rabies: A challenge for the European Union and the European Economic Area
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2020.25.38.2000158
  contributor:
    fullname: Gossner
– ident: ref_4
  doi: 10.1007/978-3-030-21084-7
– volume: 27
  start-page: 493
  year: 1938
  ident: ref_17
  article-title: A simple method of estimating fifty per cent endpoints
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/oxfordjournals.aje.a118408
  contributor:
    fullname: Reed
– volume: 3
  start-page: 98
  year: 2008
  ident: ref_18
  article-title: Analytical approach for the extraction of recombinant membrane viral glycoprotein from stably transfected Drosophila melanogaster cells
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.200700179
  contributor:
    fullname: Astray
SSID ssj0000913867
Score 2.2971668
Snippet This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 39
SubjectTerms Assaying
Baculovirus
Bioreactors
Cell culture
Cell death
Cell density
Cell viability
Design of experiments
Disease prevention
Enzyme-linked immunosorbent assay
Equivalence
Flasks
Hepatitis
Infections
Insect cells
Insects
Multiplicity of infection
Optimization
Proteins
quality by design
Rabies
rabies virus-like particles
recombinant baculovirus
RNA polymerase
Sf9 cells
stirred-tank bioreactor
Transmission electron microscopy
Vaccines
viral infection
Virus-like particles
Viruses
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlp1xK33WbFBVKoBCTtayVRsckJIRCy1I2JTcjyRJdurVDvJsm_z4z1j5DoZde9cCSZuSZj5n5xNinYMAFY3zuKfFJRhVya03MtZPCS3Q4Qk_2_PWburiUX66GVxtPfVFOWKIHTgd3VMpIDDOq9AOcbg2gwXcmEsEkIok6le4NzAaY6v_BpihB6RSXLBHXH91aT5HqDs1dQQWpW3aop-v_m4_5OFVyw_acP2NPF04jP06Lfc6ehOYFOxgl1un7Qz5eF1F1h_yAj9Z81Pcv2d1oXRzAT1fvDvI2cgKfv12fDMNPrJ9P29vJzbzjtqn5d-sQRfMf1JBPJ78CHy2z6Ph14olFmfI-54CP_7Q8sXPisKmd0fe6V-zy_Gx8epEvHlzIUSyDWR6HAApAgqmF0TY444T2Xoigh9pHiWiwlg4C2jAXCrRtToJ1ygPEgQXvytdsp2mb8JYypiCicxadr400tbJKRgPChaADhWYz9nl5_NV14tWoEI-QqKrHosrYCclnNY4YsfsG1JNqsfPqX3qSsb2ldKvFNe0qoZUWAAYgYx9X3XjBKGpim9DO-zFAbieojL1JyrBaSakoiEW70VtqsrXU7Z5m8rMn8TZELFgM3_2Pvb1nu4KqMgqRC7nHdmY387CPvtLMfeivxQNZVRTK
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELege-EF8U1hICOhSUiL1jqufX5CdNo0ITFVU4f2FtmOzSpKUpp2sP-euyRN6YR4ta3E9p19d7673zH2PhhwwRifeAp8klGFxFoTE-2k8BIVjlCDPX85V2eX8vPV6Kp9cKvasMrNnVhf1Hnp6Y38SGilBYAB-Lj4mVDVKPKutiU07rM9gZbCoMf2xifnk4vulYVQL0Hpxj-Zon1_dGM9eawrFHtDSkzdkUc1bP-_dM27IZN_yaDTR-xhqzzyTw21H7N7oXjCDiYN-vTtIZ9uk6mqQ37AJ1tc6tun7PdkmyTAj7v6g7yMnIzQH64OiuFj69fz8ma2XFfcFjm_sA6taf6VGpL57Hvgk000HV80eLFIW17HHvDpr5I3KJ04bG5X9L_qGbs8PZkenyVt4YUEyTNYJXEEoAAkmFwYbYMzTmjvhQh6pH2UaBXm0kFAWebCEGWck2Cd8gBxYMG79DnrFWURXlLkFERU0qLzuZEmV1bJaEC4EHQgF22ffdhsf7Zo8DUytEuIVNldUvXZmOjTjSNk7LqhXH7L2pVnqYyESKRSP0B2swZQQXQmEiApWp45fmR_Q92sPa5VtmWuPnvXdeNBI--JLUK5rscAqZ-g-uxFwwzdTFJFzixajd5hk52p7vYUs-sazNsQwOBw9Or_03rNHgjKuxiKRMh91lst1-ENakMr97Zl-T9CjA-U
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dixMxEA96vvgifls9JYIcCLfazabZyYOId3gcglKklb4tSTbRYt09u-15_e-dyW5be_TB103I10x25sfM_MLYK6_Beq1d4ijxSQblE2N0SHIrhZPocPhI9vz5izofy0-TwWRbHt0dYLMX2tF7UuP57M3V79V7vPDvCHEiZH97aRwFoRu0ZCnVmt5kt4REnE6JfJ2zH__LOs0gPikrELwnmc4mbdxy7yA7dirS-e_zQa-nUv5jm87usjudU8k_tFpwj93w1X12NGxZqVfHfLQtsmqO-REfbvmqVw_Y1XBbPMBPN-8S8jpwAqe_bEyW4SfGLWf15XS-bLipSv7VWETZ_Bt9SGbTn54P11l2_KLlkUWZ85iTwEd_at6yd2K3mVnQfM1DNj77ODo9T7oHGRIUW3-RhAGAApCgS6Fz4622IndOCJ8PchckosVSWvBo46xP0fZZCcYqBxD6BpzNHrGDqq78E8qogoDOW7Cu1FKXyigZNAjrfe4pdNtjr9fHX1y0vBsF4hUSVXFdVD12QvLZ9CPG7Pihnn8vup0XmQzEVKQy10c1NBrQcbQ6EFEpItISBzlcS7dYa2EhcpULAA3QYy83zXgBKapiKl8vYx8gtxRUjz1ulWGzkkxRkIt2k--oyc5Sd1uq6Y9I8q2JeDAdPP2PeZ-x24KKMlKRCHnIDhbzpX-OrtLCvog34C87uhZZ
  priority: 102
  providerName: Scholars Portal
Title Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms
URI https://www.ncbi.nlm.nih.gov/pubmed/36679884
https://www.proquest.com/docview/2767288988
https://search.proquest.com/docview/2768232486
https://pubmed.ncbi.nlm.nih.gov/PMC9867115
https://doaj.org/article/34f097263c0b42a98561b9f1753104d9
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtB6MvY9_z1gUNRmFQN7Esy9LjElrKIMWUdPTNSLK0hSV2iJN-_Pc7yXbSlD3txQ-WbMu6k-_O97ufEPpqBFdGCB1qB3yilplQSmHDVFGiKTgcxpM9jy_ZxTX9cZPc7KGkq4XxoH2tpqflbH5aTn97bOVirvsdTqyfjUfCkbJFSX8f7YOCPgrR_edXRDG0NynJGEL6_q3ULkldg6WLXC3qIXoeM5d94HTHGnnS_n95mk8Bk48s0PlL9KJ1HfH3Zoiv0J4pX6PjrOGefjjBk20pVX2Cj3G2ZaV-eIPus22JAB5tdh_ElcUuBJ0rD4nBQ6nXs-p2ulzXWJYFvpIKYmn8050IZ9M_BmfdHOFFwxYLksUeeYAndxVuODqh20yu3PPqt-j6_GwyugjbbRdCEM5gFdqEcwZzw0VBRCqNEoqkWhNi0iTVlkJMWFDFDVgyZSKwcIpyqZjm3A4k1yp-hw7KqjQfHG6KW3DRrNKFoKJgklErOFHGpMYlaAP0rZv-fNGwa-QQlTip5U-lFqChk8-mn-PF9ieq5a-8ffM8ptbxEbFYD0DZpODgHiphHR0pxJ0F3OSok27eLtY6JylLCeegDwH6smmGZeZyJ7I01dr34c755CxA7xtl2IykU6YApTtqsjPU3RbQbE_l3Wryx_--8hM6JK4gIyIhoUfoYLVcm8_gJq1UDz0bnl1mVz3_mwGOY8p7fqn8BTcfGoU
link.rule.ids 230,315,730,783,787,867,888,2109,2228,21400,24330,27936,27937,33756,33757,43817,53804,53806,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge4AXNL7LBhgJTUJatNZx7fMTotOmAlsVTR3aW2Q7NqtWktK0g_33-JI0pRPi1bYS23f23fnufkfIe6fAOKVsZDHwiXvhIq2Vj6ThzPKgcLgK7PlsJIYX_Mtl_7J5cCubsMrVnVhd1Flh8Y38kEkhGYAC-Dj7GWHVKPSuNiU07pNthKoKxtf24HiUnLevLIh6CULW_sk42PeHN9qix7oMYq-Hiakb8qiC7f-Xrnk3ZPIvGXSyQx41yiP9VFP7Mbnn8idkP6nRp28P6HidTFUe0H2arHGpb5-S38k6SYAetfUHaeEpGqE_TBUUQwfaLqfFzWS-LKnOM3quTbCm6TdsiKaTa0eTVTQdndV4sYG2tIo9oONfBa1ROsOwqV7g_8pn5OLkeHw0jJrCC1EgT3cR-T6AAOCgMqakdkYZJq1lzMm-tJ4HqzDjBlyQZcb1gowzHLQRFsB3NVgTPydbeZG7lxg5BT4oad7YTHGVCS24V8CMc9Khi7ZDPqy2P53V-BppsEuQVOldUnXIAOnTjkNk7KqhmH9Pm5WnMfeISCRi2w3sphUEBdEoj4CkwfLMwkf2VtRNm-Napmvm6pB3bXc4aOg90bkrltUYQPUTRIe8qJmhnUks0JmFq5EbbLIx1c2efHJVgXkrBBjs9V_9f1pvyYPh-Ow0Pf08-rpLHjLMweixiPE9srWYL93roBktzJuG_f8ATXgSjg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkxAviO91DDASmoS0aK3j-uMJ0bFqfFXR1KG9RbZjQ0WXlKYd7L_nLklTOiFebStxcmffne93PxPy2mtlvdYucgh84kH4yBgdImk5cxwcDl-RPX8Zi9Nz_vFicNHgn8oGVrneE6uNOiscnpEfMSkkU0pDwBYaWETyfvR2_jPCG6Qw09pcp3Gb7Egu4l6H7AxPxslZe-KCDJhKyDpXGUOsf3RlHGavSzCBfSxS3bJNFYX_v_zOm_DJv-zR6D651ziS9F0t-Qfkls8fkoOkZqK-PqSTTWFVeUgPaLLhqL5-RH4nm4IBetzeRUiLQDEgvbQVQIYOjVvNiqvpYlVSk2f0zFiIrOlXbIhm0x-eJmtkHZ3X3LEgZ1rhEOjkV0Frxk4YNjNLfF_5mJyPTibHp1FzCUMEouotozBQSijFlc6YlsZbbZl0jjEvB9IFDhFixq3yYNes74O9s1wZK5xSoWeUs_ET0smL3O8iikoFcNiCdZnmOhNG8KAVs95Lj-naLnmz_v3pvObaSCFGQVGlN0XVJUOUTzsOWbKrhmLxLW2-PI15QHYiEbseqJ7RCpxFqwOSk0IUmsFD9tfSTZulW6YbReuSV203LDrMpJjcF6tqjEJXVIkueVorQzuTWGBiC79GbqnJ1lS3e_Lp94rYWyPZYH-w9_9pvSR3QPPTzx_Gn56RuwzLMfosYnyfdJaLlX8OTtLSvmi0_w_XvRa8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+Comparison+of+Recombinant+Baculovirus+and+Rabies+Virus-like+Particles+production+Using+Two+Culture+Platforms&rft.jtitle=Vaccines+%28Basel%29&rft.au=Guardalini%2C+Luis+Giovani+Oliveira&rft.au=Cavalcante%2C+Paulo+Eduardo+da+Silva&rft.au=Leme%2C+Jaci&rft.au=Mello%2C+Renata+Gois+de&rft.date=2022-12-24&rft.issn=2076-393X&rft.eissn=2076-393X&rft.volume=11&rft.issue=1&rft_id=info:doi/10.3390%2Fvaccines11010039&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon